Solos, a leader in no- and low-alcohol (NoLo) beverage technology, has partnered with Rimuss & Strada Wein AG to launch Dealco Swiss, a new dealcoholization unit in Switzerland. This collaboration integrates Solos' patented Aroma Recovery System into local production, enhancing the quality and authenticity of alcohol-removed wines for Swiss producers. The new facility adds 10 million liters to Solos' global capacity, supporting growing demand for premium NoLo beverages in Europe and beyond. This move follows recent expansions in Spain and California, with further growth planned in Latin America.
Kelyniam Global, a leader in patient-specific cranial implants, will present at the Planet MicroCap Las Vegas conference on June 17, 2026. The company highlights its innovative regenerative platform, including the FDA-cleared Fusion™ BCP-PEEK implant...
Nvidia has partnered with Chinese startup Unitree to offer a research-focused humanoid robot system combining Unitree's H2 robot with Nvidia's advanced Jetson Thor hardware featuring the Blackwell GPU. The system targets universities and research ins...
BNP Paribas has unveiled a growth strategy for its Commercial and Personal Banking in Belgium (CPBB), aiming to boost profitability with pre-tax Return on Notional Equity (RONE) targets raised to 22% by 2028 and 25% by 2030, up from previous targets ...
New Phase 3 PRECISION study data show that Idorsia's aprocitentan significantly lowers albuminuria in patients with resistant hypertension, reducing kidney damage and cardiovascular risk. The drug demonstrated rapid, sustained reductions in urine alb...
Roche announced new Phase II data for its obesity drugs enicepatide and petrelintide at the 2026 American Diabetes Association Scientific Sessions. The data show these drugs are effective and safe for weight loss in people with overweight or obesity,...
